🇯🇵 Lyfnua in Japan

Lyfnua (GEFAPIXANT CITRATE) regulatory status in Japan.

Marketing authorisation

Lyfnua in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Pain approved in Japan

Frequently asked questions

Is Lyfnua approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for Lyfnua in Japan?

Msd K.K. is the originator. The local marketing authorisation holder may differ — check the official source linked above.